Filing Details
- Accession Number:
- 0001209191-19-056884
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 13:32:26
- Reporting Period:
- 2019-11-14
- Accepted Time:
- 2019-11-18 13:32:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1469443 | Arcadia Biosciences Inc. | RKDA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326765 | T Matthew Plavan | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-14 | 1,000 | $4.08 | 13,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
